Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Interesting👀Elephant🤔 FDA V4.0 and Sales at any time now🚀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Aug 08, 2024 9:24am
55 Views
Post# 36169208

RE:Interesting👀Elephant🤔 FDA V4.0 and Sales at any time now🚀

RE:Interesting👀Elephant🤔 FDA V4.0 and Sales at any time now🚀 ESC 2024 August 30 - September 02, 2024 | Booth F400 South | ExCel London, London, GB GE HealthCare Cardiology Solutions - Devoted to better outcomes https://gehccdxcdnprduseafi0101.blob.core.windows.net/events/wp-content/uploads/2024/06/GEHC_ESC-2024_Tutorial-Presentation-Schedules_7.31v2.pdf

jopatclo wrote: ESC 2024 August 30 - September 02, 2024 | Booth F400 South | ExCel London, London, GB https://events.gehealthcare.com/events/esc-2024/#_ GE HealthCare Cardiology Solutions - Devoted to better outcomes Overview We look forward to meeting with you to share some of the ways GE HealthCare can help you rethink the cardiology care pathway. With GE HealthCare Cardiology Solutions, you can increase collaboration, automate workflows and enable deeper insights. We're devoted to empowering heart care teams with integrated AI-powered solutions that optimize workflows, unlock efficiency and drive better patient outcomes. We know there's a lot to experience at the ESC Annual Meeting and we're excited to connect in Amsterdam.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities